Teva Pharmaceuticals USA is recalling 580,844 bottles of Prazosin Hydrochloride capsules (1 mg, 2 mg, and 5 mg strengths) due to the presence of an impurity called N-nitroso Prazosin impurity C. Testing revealed that levels of this impurity in specific lots exceed acceptable intake limits set by safety standards. This medication is used to treat high blood pressure, and consumers should check their prescription bottles to see if their medicine is part of the affected batch.
The recall is due to test results showing levels of a nitrosamine impurity above acceptable safety limits. Nitrosamines are classified as probable human carcinogens, meaning long-term exposure to levels above established limits may increase the risk of developing cancer.
You have 2 options:
Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.